NC
IMPV

Nicholas Company’s Imperva, Inc. IMPV Stock Holding History

Nicholas Company’s Portfolio IMPV Stock Details IMPV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-122,180
Closed -$6.8M – 234
2018
Q4 		$6.8M Sell
122,180
-117,230
-49% -$6.37M 0.18% 129
2018
Q3 		$11.1M Buy
239,410
+127,215
+113% +$6.16M 0.24% 109
2018
Q2 		$5.41M Hold
112,195
– – 0.13% 174
2018
Q1 		$4.86M Buy
+112,195
New +$5.04M 0.11% 181
2014
Q2 		– Sell
-40,330
Closed -$2.25M – 259
2014
Q1 		$2.25M Buy
40,330
+115
+0.3% +$6.62K 0.05% 216
2013
Q4 		$1.94M Buy
40,215
+15,055
+60% +$633K 0.05% 225
2013
Q3 		$1.06M Buy
25,160
+5,035
+25% +$240K 0.03% 229
2013
Q2 		$906K Buy
+20,125
New +$789K 0.03% 229

Nicholas Company's IMPV Position: Q1 2019 in Review

Nicholas Company sold out of Imperva, Inc. (IMPV) in Q1 2019, closing a stake of 122,180 shares — an estimated $6.8M sold.

Nicholas Company first reported a position in IMPV in Q2 2013 and held it in 8 quarters. The position peaked at $11.1M in Q3 2018. 0 funds tracked by Wall St. Rank hold IMPV as of Q1 2019.

  • Nicholas Company reported no remaining Imperva, Inc. position as of Q1 2019 after selling out during the quarter.
  • Nicholas Company sold 122,180 Imperva, Inc. shares in Q1 2019, an estimated $6.8M.
  • Nicholas Company first reported a position in Imperva, Inc. in Q2 2013 and held it in 8 quarters.
  • Nicholas Company's Imperva, Inc. position peaked at $11.1M in Q3 2018.
  • 0 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2019.

Based on Nicholas Company's 13F filing for Q1 2019, filed 14 May 2019.